The interaction of secreted phospholipase A2-IIA with the microbiota alters its lipidome and promotes inflammation
- JCI Insight. 2022 Jan 25;7(2):e152638. doi: 10.1172/jci.insight.152638.
- 1. CHU de Québec-Université Laval Research Center, Department of Microbiology, Infectiology and Immunology, Quebec City, Quebec, Canada.
- 2. ARThrite Research Center, University Laval, Quebec City, Quebec, Canada.
- 3. CHU de Québec-Université Laval Research Center, Endocrinology and Nephrology Axis, Quebec City, Quebec, Canada.
- 4. Laboratory for Metabolomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
- 5. Division of Physiological Chemistry and Metabolism, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.
- 6. Côte d'Azur University, The French National Centre for Scientific Research, Institute of Molecular and Cellular Pharmacology, UMR7275, Valbonne Sophia Antipolis, France.
- 7. The Research Center of the University Institute of Cardiology and Pneumology of Quebec, Quebec City, Quebec, Canada.
- 8. Department of Chemistry, University of Washington, Seattle, Washington, USA.
- 9. CHU de Québec-Université Laval Research Center, Neurosciences Axis, Quebec City, Quebec, Canada.
- 10. Laboratory of Microenvironmental and Metabolic Health Science, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- 11. Cellular and Molecular Epigenetics Laboratory, Graduate School of Medical Life Science, Yokohama-City University, Yokohama, Japan.
Secreted Phospholipase A2-IIA (sPLA2-IIA) hydrolyzes Phospholipids to liberate lysophospholipids and Fatty Acids. Given its poor activity toward eukaryotic cell membranes, its role in the generation of proinflammatory lipid mediators is unclear. Conversely, sPLA2-IIA efficiently hydrolyzes Bacterial membranes. Here, we show that sPLA2-IIA affects the immune system by acting on the intestinal microbial flora. Using mice overexpressing transgene-driven human sPLA2-IIA, we found that the intestinal microbiota was critical for both induction of an immune phenotype and promotion of inflammatory Arthritis. The expression of sPLA2-IIA led to alterations of the intestinal microbiota composition, but housing in a more stringent pathogen-free facility revealed that its expression could affect the immune system in the absence of changes to the composition of this flora. In contrast, untargeted lipidomic analysis focusing on bacteria-derived lipid mediators revealed that sPLA2-IIA could profoundly alter the fecal lipidome. The data suggest that a singular protein, sPLA2-IIA, produces systemic effects on the immune system through its activity on the microbiota and its lipidome.
-
Cat. No.Product NameDescriptionTargetResearch Area
-